Enalaprilat - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:56:48Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:56, 20 March 2026
Line 51:		Line 51:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:26:34Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:26, 20 March 2026
Line 53:		Line 53:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:44:43Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Line 40: / Line 40: @@
 *Inhibits angiotensin converting enzyme, blocking conversion of angiotensin I to angiotensin II.
 ==Comments==
 ==See Also==

Elcatracho: /* See Also */

2021-03-08T16:00:14Z

ClaireLewis: /* References */

2019-09-22T19:10:53Z

References

← Older revision		Revision as of 19:10, 22 September 2019
Line 46:		Line 46:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:Cardiology]]

Rossdonaldson1: Text replacement - "CHF" to "CHF"

2016-09-24T17:34:16Z

Text replacement - "*CHF" to "*CHF"

← Older revision		Revision as of 17:34, 24 September 2016
Line 10:		Line 10:
	**CrCl <30		**CrCl <30
	**Severe volume or salt depletion, recent HD, or concomitant diuretic use		**Severe volume or salt depletion, recent HD, or concomitant diuretic use
	**CHF		**[[CHF]]
	==Pediatric Dosing==		==Pediatric Dosing==
	''Safety/efficacy not established''		''Safety/efficacy not established''

Rossdonaldson1: Text replacement - "Hyperkalemia" to "Hyperkalemia"

2016-09-24T15:22:58Z

Text replacement - "*Hyperkalemia" to "*Hyperkalemia"

← Older revision		Revision as of 15:22, 24 September 2016
Line 29:		Line 29:
	*Angioedema		*Angioedema
	===Common===		===Common===
	*Hyperkalemia		*[[Hyperkalemia]]
	*Nausea		*Nausea
	*Headache		*Headache

Neil.m.young: Text replacement - "5 mg" to "5mg"

2016-07-19T10:28:10Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 10:28, 19 July 2016
Line 7:		Line 7:
	==Adult Dosing==		==Adult Dosing==
	*1.25-5mg IV q6h		*1.25-5mg IV q6h
	*0.~~625 mg~~ IV initially, with repeated dose of 0.625mg if inadequate response for the following patients:		*0.625mg IV initially, with repeated dose of 0.625mg if inadequate response for the following patients:
	**CrCl <30		**CrCl <30
	**Severe volume or salt depletion, recent HD, or concomitant diuretic use		**Severe volume or salt depletion, recent HD, or concomitant diuretic use

ClaireLewis: Created page with "==Administration== Type: ACE inhibitor Dosage Forms: Routes of Administration: IV Common Trade Names: Vasotec ==Adult Dosing== 1.25-5mg IV q6h 0.625 mg IV initially..."

2016-07-15T21:06:45Z

Created page with "==Administration== *Type: ACE inhibitor *Dosage Forms: *Routes of Administration: IV *Common Trade Names: Vasotec ==Adult Dosing== *1.25-5mg IV q6h *0.625 mg IV initially..."

New page

==Administration==
*Type: [[ACE inhibitor]]
*Dosage Forms:
*Routes of Administration: IV
*Common Trade Names: Vasotec

==Adult Dosing==
*1.25-5mg IV q6h
*0.625 mg IV initially, with repeated dose of 0.625mg if inadequate response for the following patients:
**CrCl <30
**Severe volume or salt depletion, recent HD, or concomitant diuretic use
**CHF
==Pediatric Dosing==
''Safety/efficacy not established''
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
*[[Lactation risk categories|Lactation risk]]: Infant risk minimal
===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug
*Angioedema history (ACEi-induced, hereditary, or idiopathic)
==Adverse Reactions==
===Serious===
*Myocardial infarction
*Liver failure
*Angioedema
===Common===
*Hyperkalemia
*Nausea
*Headache
==Pharmacology==
*Half-life: ~11h
*Metabolism:
*Excretion: Renal. Dialyzable

==Mechanism of Action==
*Inhibits angiotensin converting enzyme, blocking conversion of angiotensin I to angiotensin II.
==Comments==

==See Also==

==References==
<references/>
[[Category:Pharmacology]]

← Older revision		Revision as of 16:00, 8 March 2021
Line 42:		Line 42:

	==See Also==		==See Also==
			*[[Hypertension]]
			*[[ACE inhibitor]]

	==References==		==References==